Bronson David M. 4

What Happened David M. Bronson, a director of CONMED Corporation (CNMD), received a grant of 5,772 restricted stock units (RSUs) on 2026-06-01 (reported as an award, code A). The filing also shows a conversion/exercise of 668 derivative units on 2026-06-02 (code M) with an immediate disposition of 668 derivative shares the same day. All transactions are reported at $0.00 per share in the filing (no cash amount reported). The Form 4 was filed on 2026-06-03.

Key Details

• Transactions: 5,772 RSUs granted (6/1/2026, code A); 668 derivative units exercised/converted and 668 derivative shares disposed (6/2/2026, code M).
• Price/value: reported at $0.00 per share for both acquisition and disposition entries (filing shows $0 total).
• Shares owned after transaction: not specified in the provided filing data.
• Footnotes: RSUs represent contingent rights to one common share each and are subject to the Company’s 2025 Long-Term Incentive Plan; RSUs generally vest 100% after one year (see footnotes F1/F2).
• Timeliness: Filing date 2026-06-03 covering transactions on 6/1–6/2 — appears to be filed within the normal Form 4 reporting window.

Context

• RSU awards are a form of compensation and typically vest over time; these RSUs are documented as vesting 100% after one year per the plan terms. The code M indicates exercise or conversion of a derivative security (here, conversion/exercise of derivative units into shares). The 668-share disposition reported at $0.00 suggests shares were surrendered/converted rather than sold for cash, but the filing does not specify the reason (e.g., tax withholding). Director grants and routine conversions are commonly part of compensation arrangements and do not by themselves indicate the director’s market view.